Keita Hirano

Keita Hirano

Auto-generated profile, based on publicly available information

Keita Hirano

The Jikei University School of Medicine Division of Nephrology and Hypertension, Department of Internal Medicine Tokyo

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2015 in Clinical and Experimental Nephrology
Verified
Journal Article
Open access
PDF file
KHKeita Hirano
Keita Hirano
HAHoichi Amano
Hoichi Amano
TKTetsuya Kawamura
Tetsuya Kawamura
KWKyoko Watanabe
Kyoko Watanabe
KKKentaro Koike
Kentaro Koike
TYTakashi Yokoo
Takashi Yokoo
In patients with IgA nephropathy (IgAN), recurrence after steroid pulse therapy is associated with reduced renal survival. However, the predictors of recurrence have not yet been clarified. All patients who received 6-month steroid pulse therapy from 2004 to 2010 in our four affiliated hospitals and achieved a reduction of proteinuria to <0.4 g/day 1 year after treatment were retrospectively evaluated. The primary outcome was proteinuria ≥1.0 g/day during follow-up or additional antiproteinuric therapy. Two histological classifications were evaluated, the Oxford Classification with a split system and Japanese histological grades (HGs) with a lumped system. During a median follow-up of 3.4 years, 27 (26.7 %) of the 101 patients showed recurrence. Multivariate analysis showed that HG was the only significant predictor of recurrence, with HG 2+3+4 vs HG 1 having a hazard ratio of 7.38 (95 % confidence interval 1.52–133). Furthermore, in patients with mesangial hypercellularity according to the Oxford Classification, cumulative rate of recurrence-free survival was greater in patients with steroid therapy plus tonsillectomy compared with those who received steroid therapy alone (Log-rank test, P = 0.022). However, this association was not observed in patients without mesangial hypercellularity. HG is a novel predictor of recurrence after steroid pulse therapy in patients with IgAN. Moreover, the combination of steroid pulse therapy plus tonsillectomy may indicate a lower risk of recurrence in patients with mesangial hypercellularity, as defined by the Oxford Classification.

22 March 2019 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
TKToshiki Kuno
Toshiki Kuno
KHKeita Hirano
Keita Hirano
TATakayuki Abe
Takayuki Abe
SIShohei Imaeda
Shohei Imaeda
KHKenji Hashimoto
Kenji Hashimoto
YNYohei Numasawa
Yohei Numasawa

1 September 2019 in Oxford Medical Case Reports
Verified
Journal Article
Open access
PDF file
TNTakashin Nakayama
Takashin Nakayama
YNYohei Numasawa
Yohei Numasawa
KHKohei Hashimoto
Kohei Hashimoto
KHKeita Hirano
Keita Hirano
An 82-year-old woman presented with chest pain and exertional dyspnea for 1 week. Her medical history was unremarkable, except for controlled hypertension. Electrocardiography revealed ST-segment elevation in most leads (Fig. 1); echocardiography revealed a pericardial effusion collection without any segmental wall motion abnormalities, indicating acute pericarditis. Laboratory findings were not suggestive of infections or autoimmune diseases; her serum tumor marker tests were negative. Contrast-enhanced computed tomography revealed an irregular periaortic mass (Fig. 2A1 and A2). Pericardial and pleural effusion aspirate was both unremarkable. Therefore, mediastinal mass biopsy was performed, suggesting sarcoma not otherwise specified. The tumor deemed unresectable. The patient opted for palliative care and died of right cardiac failure in a month. Autopsy revealed that a white elastic tumor surrounded the aorta and pulmonary artery without protrusion into the vascular cavity and wholly occupied the pericardial cavity with slight infiltration into the myocardium (Fig. 2B1 and B2). According to the 2013 WHO classification, the histological type was compatible with undifferentiated high-grade pleomorphic sarcoma (UHPS) [1].

20 August 2015 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
MTMai Tanaka
Mai Tanaka
YMYoichi Miyazaki
Yoichi Miyazaki
KKKentaro Koike
Kentaro Koike
HUHiroyuki Ueda
Hiroyuki Ueda
NTNobuo Tsuboi
Nobuo Tsuboi
TYTakashi Yokoo
Takashi Yokoo

7 July 2025 in Clinical Kidney Journal
Verified
Journal Article
Open access
HKHideaki Kuno
Hideaki Kuno
GKGo Kanzaki
Go Kanzaki
RORina Oba
Rina Oba
HMHirokazu Marumoto
Hirokazu Marumoto
SHSaeko Hatanaka
Saeko Hatanaka
TYTakashi Yokoo
Takashi Yokoo
Background: Sodium–glucose co-transporter 2 inhibitors (SGLT2i) reduce glomerular hyperfiltration, resulting in an initial estimated glomerular filtration rate (eGFR) dip in chronic kidney disease (CKD). The association between the initial eGFR dip after SGLT2i and proteinuria reduction has not been explored. Fractional excretion of total protein (FETP) is an index of protein leakage corrected for GFR and may be useful in addressing this issue. Methods: FETP was calculated as (serum creatinine × urine protein)/(serum protein × urine creatinine) (in %) and the initial FETP dip was defined as 3 months/baseline FETP. The patients were divided into three groups according to the initial FETP dip tertile: FETP acute dipper, moderate dipper and riser. The association between initial FETP dip after SGLT2i and the eGFR slope over the subsequent 2 years was retrospectively investigated. Results: The study involved 238 patients, including 105 with diabetes mellitus. The patients’ median age was 57.0 years and eGFR was 43.0 ml/min/1.73 m2. The initial FETP dip was associated with the baseline eGFR, protein:creatinine ratio and FETP. The eGFR slope in the FETP acute dipper was −0.2 ml/min/1.73 m2/year, which was less than those of the moderate dipper and riser (−1.0 and −1.3 ml/min/1.73 m2/year; P < .001). Multivariate regression analyses revealed that the initial FETP dip was associated with the eGFR slope independent of potential confounders (P < .001). Conclusions: An FETP acute dip after SGLT2i is associated with a favourable renal prognosis in CKD, indicating that FETP is a useful index for assessing the efficacy of SGLT2i.

27 August 2025 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
HKHiroshi Kataoka
Hiroshi Kataoka
SMShun Manabe
Shun Manabe
TMTakahito Moriyama
Takahito Moriyama
YUYusuke Ushio
Yusuke Ushio
KNKosaku Nitta
Kosaku Nitta
YSYusuke Suzuki
Yusuke Suzuki
Background and hypothesis: Attribute-based medicine emphasizes tailoring care to patient-specific characteristics. Immunoglobulin A nephropathy (IgAN), a heterogeneous glomerular disease, presents varying risks across subgroups. We hypothesized that an attribute-based medicine approach could identify residual risk factors and inform personalized strategies. Methods: We analysed data from 996 patients from the Japanese Nationwide Retrospective Cohort Study in IgAN. The primary outcome was kidney replacement therapy initiation or a 1.5-fold increase in serum creatinine. Six pre-specified attributes were assessed: age, sex, body mass index (BMI), chronic kidney disease (CKD) stage, urinary protein excretion (U-Prot) and urine occult blood (U-OB). Cox regression and Kaplan–Meier analyses were performed to evaluate interactions between attributes and risk factors. Results: Poor kidney prognosis was associated with lower estimated glomerular filtration rate (eGFR) [per 10 mL/min/1.73 m² increase, hazard ratio (HR) = 0.87], higher U-Prot (log-transformed HR = 4.54) and hyperuricaemia (HR = 1.64), while oral corticosteroids (HR = 0.60) and tonsillectomy (HR = 0.44) were protective factors. Significant interactions included the following: hyperuricaemia with BMI <22 kg/m²; hypertension with female sex; eGFR and age with CKD stage; U-Prot with age, eGFR and corticosteroid use; and U-Prot with U-OB. Prognostic effects of age and eGFR were reversed for CKD stage 3 compared with stages 1–2. U-Prot was the most consistent predictor of poor prognosis, especially in patients with U-OB ≤2+. Corticosteroids improved outcomes in patients with U-Prot ≥1 g/day, while tonsillectomy was effective in those with U-OB ≥3+. Conclusion: Attribute-based analysis revealed critical risk modifiers and supported stratified treatment strategies for IgAN. These findings underscore the potential of attribute-based medicine in guiding personalized care for patients with IgAN.